Pomerantz Law Firm Probes NeoGenomics, Inc. as Investor Concerns Mount Over Revenue Growth Discrepancies,
On September 10, 2025, Pomerantz LLP announced an investigation into potential claims on behalf of investors in NeoGenomics, Inc. (NASDAQ: NEO), a leading cancer diagnostic and genomic testing company. The firm is exami...
Sep 10, 2025
• IT Infrastructure Industry
Announcement
Uncertain M
